Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor

Molecular Pharmacology

Volumn 50, Issue 2, 1996, Pages 285-292

  Sautel, Martine ^a   Rudolf, Klaus ^b   Wittneben, Helmut ^b   Herzog, Herbert ^c   Martinez, Raquel ^a   Munoz, Miguel ^a   Eberlein, Wolfgang ^b   Engel, Wolfhard ^b   Walker, Philippe ^a   Beck Sickinger, Annette G ^d  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; TRITIUM;

AMINO ACID SUBSTITUTION; ARTICLE; DRUG RECEPTOR BINDING; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR AFFINITY; RECEPTOR BLOCKING; THREE DIMENSIONAL IMAGING;

AMINO ACID SEQUENCE; ARGININE; BINDING SITES; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEUROPEPTIDE Y; RECEPTORS, NEUROPEPTIDE Y; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 9444264701     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Allen, J., J. Novotny, J. Martin, and G. Heinrich. Molecular structure of mammalian neuropeptide Y: analysis by molecular cloning and computer-aided comparison with crystal structure of avian homologue. Proc. Natl. Acad. Sci. USA 84:2532-2536 (1987).
2. Tatemoto, K., M. Carlquist, and V. Mutt. Neuropeptide Y: a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature (Lond.) 296:659-660 (1982).
3. Zukowska-Grojec, Z., and C. Wahlestedt. Origin and actions of neuropeptide Y in the cardiovascular system, in The Biology of Neuropeptide Y and Related Peptides (W. F. Colmers and C. Wahlestedt, eds.). Humana Press, Totowa, NJ, 315-388 (1993).
4. Grundemar, L., S. P. Sheikh, and C. Wahlestedt. Characterization of receptor types for neuropeptide Y and related peptides, in The Biology of Neuropeptide Y and Related Peptides (W. F. Colmers and C. Wahlestedt, eds.). Humana Press, Totowa, NJ, 197-239 (1993).
5. Wahlestedt, C., and D. J. Reis. Neuropeptide Y-related peptides and their receptors: are the receptors potential therapeutic drug targets? Annu. Rev. Pharmacol. Toxicol. 32:309-352 (1993).
6. Colmers, W. F., and D. Bleakman. Effects of neuropeptide Y on the electrical properties of neurons (Review). Trends Neurosci. 17:373-379 (1994).
7. 2 receptors (Review). Biopolymers (Peptide Sci.) 37:123-142 (1995).
8. Wahlestedt, C., N. Yanaihara, and R. Håkanson. Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides. Regul. Peptides 13:307-318 (1986).
9. 1 receptor agonist. Proc. Natl. Acad. Sci. USA 87:182-186 (1990).
10. 2-selective reduced size agonists of neuropeptide Y. Bioorg. Med. Chem. Lett. 3:937-942 (1993).
11. Rudolf, K., W. Eberlein, W. Engel, H. Wieland, K. D. Willim, M. Entzeroth, W. Wienen, A. G. Beck-Sickinger, and H. N. Doods. The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP 3226. Eur. J. Pharmacol. 271:R11-R13 (1994).
12. Doods, H. N., W. Wienen, M. Entzeroth, K. Rudolf, W. Eberlein, W. Engel, and H. A. Wieland. Pharmacological characterization of BIBP 3226, the first selective non peptide NPY Y1 receptor antagonist. J. Pharmacol. Exp. Ther. 275:136-142 (1995).
13. Eva, C., K. Keinänen, H. Monyer, P. Seeburg, and R. Sprengel. Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Lett. 271:80-84 (1990).
14. 1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. Mol. Pharmacol. 41:817-821 (1992).
15. Herzog, H., Y. Hort, H. J. Ball, G. Hayes, J. Shine, and L. A. Selbie. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc. Natl. Acad. Sci. USA 89:5794-5798 (1992).
16. 1 type. J. Biol. Chem. 267:10935-10938 (1992).
17. Walker, P., M. Munoz, R. Martinez, and M. C. Peitsch. Acidic residues in extracellular loops of the human Y1 neuropeptide Y receptor are essential for ligand binding. J. Biol. Chem. 269:2863-2869 (1994).
18. 2 receptors with distinguished conformations. Eur. J. Biochem. 225:947-958 (1994).
19. 1 neuropeptide Y receptor in ligand binding. Mol. Cell. Endocrinol. 112:215-222 (1995).
20. Walker, P., M. Munoz, M.-C. Combe, E. Grouzmann, H. Herzog, L. Selbie, J. Shine, H. R. Brunner, B. Waeber, B., and R. Wittek. High level expression of human neuropeptide Y receptors in mammalian cells infected with a recombinant vaccinia virus. Mol. Cell. Endocrinol. 91:107-112 (1993).
21. Deng, W. P., and J. A. Nickoloff. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200:81-86 (1992).
22. McPherson, G. A. A practical computer-based approach to the analysis of radioligand binding experiments. Comput. Programs Biomed. 17:107-114 (1983).
23. Marshall, G. R. Computer aided drug design: the active analog approach, in Proceedings of the 6th International Symposium on Medicinal Chemistry (A. Simkin, ed.). Cotswold Press, Oxford, 225-235 (1979).
24. Vriend, G. WHAT IF: a molecular modeling and drug design program. J. Mol. Graph. 8:52-56 (1990).
25. Kearney, P. C., L. S. Mizoue, R. A. Kumpf, J. E. Forman, A. McCurdy, and D. A. Dougherty. Molecular recognition in aqueous media: new binding studies provide further insights into the cation-pi interaction and related phenomena. J. Am. Chem. Soc. 115:9907-9919 (1993).
26. Schwartz, T. W. Locating ligand-binding sites in 7TM receptors by protein engineering. Curr. Opin. Biotechnol. 5:434-444 (1994).
27. Unger, V. M., and G. F. X. Schertler. Low resolution structure of bovine rhodopsin determined by electron cryo-microscopy. Biophys. J. 68:1776-1786 (1995).
28. Schertler, G. F., C. Villa, and R. Henderson. Projection structure of rhodopsin. Nature (Lond.) 362:770-772 (1993).
29. Trumpp-Kallmeyer, S., J. Hoflack, A. Bruinvels, and M. Hibert. Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J. Med. Chem. 35: 3448-3462 (1992).
30. Gether, U., T. E. Johansen, and T. W. Schwartz. Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonists. Nature (Lond.) 362:345-348 (1993).
31. Nardone, J., and P. G. Hogan. Delineation of a region in the B2 bradykinin receptor that is essential for high-affinity agonist binding. Proc. Natl. Acad. Sci. USA 91:4417-4421 (1994).
32. Mantamadiotis, T., and G. S. Baldwin. The seventh transmembrane domain of gastrin/CCK receptors contributes to non-peptide antagonist binding. Biochem. Biophys. Res. Commun. 201:1382-1389 (1994).
33. Lee, J. A., J. A. Brinkmann, E. D. Longton, C. E. Peishoff, M. A. Lago, J. D. Leber, R. D. Cousins, A. Gao, J. M. Stadel, C. S. Kumar, E. H. Ohlstein, J. G. Gleason, and J. D. Elliott. Lysine 182 of endothelin B receptor modulates agonist selectivity and antagonist affinity: evidence for the overlap of peptide and non-peptide ligand binding sites. Biochemistry 33:14543-14549 (1994).
34. Gether, U., Y. Yokota, X. Emonds-Alt, J.-C. Breliere, J. A. Lowe III, R. M. Snider, S. Nakanishi, and T. W. Schwartz. Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors. Proc. Natl. Acad. Sci. USA 90:6194-6198 (1993).
35. Fong, T. M., M. A. Cascieri, H. Yu, A. Bansal, C. Swain, and C. D. Strader. Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345. Nature (Lond.) 362:350-353 (1993).
36. Schambye, H. T., S. A. Hjorth, D. J. Bergsma, G. Sathe, and T. W. Schwartz. Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors. Proc. Natl. Acad. Sci. USA 91:7046-7050 (1994).
37. Wang, J. B., P. S. Johnson, J. M. Wu, W. F. Wang, and G. R. Uhl. Human κ-opiate receptor second extracellular loop elevates dynorphin's affinity for human μ/κ chimeras. J. Biol. Chem. 269:25966-25969 (1994).
38. Hoffman, S., B. Rist, G. Videnov, G. Jung, and A. G. Beck-Sickinger. Structure-affinity studies of C-terminally modified analogs of neuropeptide Y led to a novel class of peptidic Y1 receptor antagonists. Regul. Pept., in press.
39. Ohlstein, E. H., P. Nambi, S. A. Douglas, R. M. Edwards, M. Gellai, A. Lago, J. D. Leber, R. D. Cousins, A. Gao, J. S. Frazee, C. E. Peishoff, J. W. Bean, D. S. Eggleston, N. A. Elshourbagy, C. Kumar, J. A. Lee, T.-L. Yue, C. Louden, D. P. Brooks, J. Weinstock, G. Feuerstein, G. Poste, R. R. Ruffolo, Jr., and J. G. Gleason. SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist. Proc. Natl. Acad. Sci. USA 91:8052-8056 (1994).